IL10 and metabolic dysfunction-associated steatohepatitis: On the contrary, Bertola et al detected a shift towards the opposite direction in liver samples of NASH patients compared to S3 obese patients and obese S0 patients assessed by an increase in IL-10/IFNγ ratio [40].